Quantification and characterization of protein loss in continuous ambulatory peritoneal dialysis

Revista de Investigacion Clinica

Volumn 52, Issue 6, 2000, Pages 611-617

  Cueto Manzano, Alfonso M ^a   Gamba, Gerardo ^b,c   Correa Rotter, Ricardo ^c  

^a HOSPITAL DE ESPECIALIDADES   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^c INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Albumin; CAPD; IgA; IgG; IgM; Mexican and Latinamerican patients; Peritoneal protein loss; Peritoneal transport

Indexed keywords

ALBUMINOID; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADULT; ARTICLE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED;

ADULT; ALBUMINS; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY;

EID: 0034328975     PISSN: 00348376     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Young GA, Kopple JD, Lindholm B et al. Nutritional assessment of continuous ambulatory peritoneal dialysis patients: an international study. Am J Kidney Dis 1991; 17: 462-71.
2. Espinosa MA, Cueto-Manzano AM, Velázquez-Alva C et al. Prevalence of malnutrition in Mexican CAPD diabetic and non-diabetic patients. Adv Perit Dial 1996; 12: 302-06.
3. Spiegel DM, Anderson M, Campbell U, Hall K, Kelly G, McClure E, Breyer JA. Serum albumin: a marker for morbidity in peritoneal dialysis patents. Am J Kidney Dis 1993; 21: 26-30.
4. Gamba G, Mejía JL, Saldívar S, Peña JC, Correa-Rotter R. Death risk in CAPD patients. Nephron 1993; 65: 23-27.
5. Blake PG, Flowerdew G, Blake RM, Oreopoulos DG. Serum albumin in patients on continuous ambulatory peritoneal dialysis -predictors and correlations with outcomes. J Am Soc Nephrol 1993; 3: 1501-07.
6. CANADA-USA (CANUSA) Peritoneal Dialysis Study Group. Adequacy of dialysis and nutrition in continuous ambulatory peritoneal dialysis: association with clinical outcomes. J Am Soc Nephrol 1996; 7: 198-207.
7. Díaz AA, Gamba G, Abasta-Jiménez M, Correa-Rotter R. Serum albumin and body surface area are the strongest predictors of the peritoneal transport type. Adv Perit Dial 1994; 10: 47-51.
8. Cueto-Manzano AM. Quantification of the protein losses on continuous ambulatory peritoneal dialysis according the peritoneal membrane transport type, and its modification with short-dwell time dialysis. Thesis of Master in Medical Sciences. National Autonomous University of Mexico, 1997.
9. Harty JC, Boulton H, Venning MC, Gokal R. Is peritoneal permeability an adverse risk factor for malnutrition in CAPD patients? Miner Electrolyte Metab 1996; 22: 97-101.
10. Kagan A, Bar-Khayim Y, Schafer Z, Fainaru M. Heterogeneity in peritoneal transport during continuous ambulatory peritoneal dialysis and its impact on ultrafiltration, loss of macromolecules and plasma level of proteins, lipids and lipoproteins. Nephron 1993; 63: 32-42.
11. Cueto-Manzano AM, Correa-Rotter R. Is the high peritoneal transport rate an independent risk factor for CAPD mortality? Kidney Int 2000; 57: 314-320.
12. Churchill DN, Thorpe KE, Nolph KD, Keshaviah PR, Oreopoulos DG. Pagé D, for the Canada-USA (CANUSA) Peritoneal Dialysis Study Group. Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients. J Am Soc Nephrol 1998; 9: 1285-92.
13. Ching-Herng W, Chiu-Ching H, Jeng-Yi H, Mai-Szu W, Mei-Ling L. High flux peritoneal membrane is a risk factor in survival of CAPD treatment. Adv Perit Dial 1996; 12: 105-09.
14. Lindholm B, Bergström J. Nutritional requirements of peritoneal dialysis patients, in the textbook of peritoneal dialysis, edited by Gokal R, Nolph KD, Dordrecht, Kluwer Academic Publishers, 1994: 443-72.
15. Twardowski ZJ, Nolph KD, Khanna R et al. Peritoneal equilibration test. Perit Dial Bull 1987; 7: 138-47.
16. Cueto-Manzano AM, Díaz-Alvarenga A, Correa-Rotter R. Analysis of the peritoneal equilibration test in Mexico and of factors influencing the peritoneal transport rate. Perit Dial Int 1999; 19: 45-50.
17. Dubois D, Dubois EF. A formula to estimate the approximate surface area if height and weight be known. Arch Int Med 1916; 17: 863-71.
18. Randerson DH, Chapman GV, Farrell PC. Amino acid and dietary status in CAPD patients, in Peritoneal Dialysis, edited by Atkins RC, Farrell PC, Thomson N, Edinburgh, Churchill-Livingstone, 1981: 180-91.
19. Kagan A, Bar-Khayim Y, Schafer Z, Fainaru M. Kinetics of peritoneal protein loss during CAPD: I. Different characteristics for low and high molecular weight proteins. Kidney Int 1990; 37: 971-79.
20. Imholz ALT, Koomen GCM, Struijk DG, Arisz L, Krediet RT. Effect of dialysate osmolarity on the transport of low-molecular weight solutes and proteins during CAPD. Kidney Int 1993; 43: 1339-46.
21. Cueto-Manzano AM, Espinosa A, Herndndez A, Correa-Rotter R. Peritoneal transport kinetics correlate with serum albumin but not with the overall nutritional status in CAPD patients. Am J Kidney Dis 1997; 30: 229-36.
22. Cueto-Manzano AM. Hipoalbuminemia en diálisis. ¿Es marcador de desnutrición o de inflamación? Rev Invest Clin 2000 (en prensa).
23. Blake P, Burkart JM. Churchill DN, Daurgidas J, Depner T, Hamburger RJ, Hull AR, Korbet SM, Moran J, Nolph KD, Oreopoulos DG, Schreiber M, Soderbloom R. Recommended clinical practices for maximizing peritoneal dialysis clearances. Perit Dial Int 1996; 16: 448-56.
24. Twardowski ZJ, Khanna R, Nolph KD. Peritoneal dialysis modifications to avoid CAPD drop-out, in advances in peritoneal dialysis, edited by Khanna R, Nolph KD, Prowant B, Twardowski ZJ, Oreopoulos DG, Peritoneal Dialysis Bulletin Inc., 1987: 171-178.
25. Strauss FG, Holmes DL, Dennis RL. Dialysis adequacy indices in high membrane transporters treated with short-dwell peritoneal dialysis. Adv Perit Dial 1995; 11: 110-13.